Kidney Diseases Completed Phase 2 Trials for Sorafenib (DB00398)

Also known as: Renal Disease / Renal Diseases / Kidney Disease / Nephropathies / Nephropathy / Nephropathy NOS / Pyoureter / Kidney disorder / Disorder kidney / Renal disorder NOS / Disorder renal / Renal disorder

IndicationStatusPhase
DBCOND0028223 (Kidney Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00854620Safety and Toxicity Study of Sorafenib in Patients With Kidney CancerTreatment